Suppression of cholesterogenesis and reduction of LDL cholesterol by dietary ginseng and its fractions in chicken liver
- PMID: 6882511
- DOI: 10.1016/0021-9150(83)90019-9
Suppression of cholesterogenesis and reduction of LDL cholesterol by dietary ginseng and its fractions in chicken liver
Abstract
The effects of ginseng root powder and of serially extracted solvent fractions of ginseng on avian hepatic cholesterol metabolism and lipogenesis and on avian serum lipoprotein cholesterol levels were examined. In one study, White Leghorn females were fed for 4 weeks a corn-based diet (control) or an experimental diet in which was incorporated 0.25% Wisconsin ginseng or an equivalent quantity of a serial solvent fraction [petroleum ether (PESF), methyl alcohol (MESF), water (WASF)] or of the residue. beta-hydroxy-beta-methylglutaryl-CoA (HMG-CoA) reductase activity was significantly lower (P less than 0.01) in each of the treatment groups (31-37% of control activity) except that fed the extracted residue (90% of control, N.S.). Cholesterol 7 alpha-hydroxylase activity was lowered in parallel (45-64% of control, P less than 0.01) by all treatments except the residue (100% of control). Also with the exception of the residue treatment, each ginseng treatment effected a lowering of the serum total cholesterol level (67-83% of control, P less than 0.01) and of serum low density lipoprotein cholesterol level (53-81% of control, P less than 0.01). Lipogenic activities and serum triglycerides levels were lowered (P less than 0.01) by two of the ginseng treatments. The PESF treatment was the most effective suppressor of each parameter, 74% and 68% respectively, of the control values. The WASF also had significant impact. Not one of the experimental diets influenced the serum high density lipoprotein level. The PESF, the potent source of suppressors, effected a change in the ratio of low to high density lipoprotein cholesterol from 1.46 (control) to 0.88. The levels of cholesterol and triglycerides in liver under these conditions showed a similar pattern as that of serum. In companion studies, broiler females were fed 0.28% Chinese red ginseng root powder or its various fractions. The results confirmed those recorded above. The factor(s) responsible for lowering the serum total and low density lipoprotein cholesterol levels were generally more concentrated in the PESF and WASF of ginseng and each was significantly more effective than was ginseng root powder. Ginsenosides (saponins) are considered to be the active agents for the suppression of cholesterogenesis and lipogenesis.
Similar articles
-
Suppression of cholesterol biosynthesis by constituents of barley kernel.Atherosclerosis. 1984 Apr;51(1):75-87. doi: 10.1016/0021-9150(84)90145-x. Atherosclerosis. 1984. PMID: 6721904
-
Inhibition of cholesterol and fatty acid biosynthesis in liver enzymes and chicken hepatocytes by polar fractions of garlic.Lipids. 1983 May;18(5):343-8. doi: 10.1007/BF02537229. Lipids. 1983. PMID: 6877039
-
Suppression of avian hepatic cholesterogenesis by dietary ginseng.J Nutr Biochem. 1990 Oct;1(10):518-21. doi: 10.1016/0955-2863(90)90034-i. J Nutr Biochem. 1990. PMID: 15539168
-
Effects of Panax ginseng on hyperglycemia, hypertension, and hyperlipidemia: A systematic review and meta-analysis.J Ginseng Res. 2022 Mar;46(2):188-205. doi: 10.1016/j.jgr.2021.10.002. Epub 2021 Oct 13. J Ginseng Res. 2022. PMID: 35509826 Free PMC article. Review.
-
Panax ginseng: Inflammation, platelet aggregation, thrombus formation, and atherosclerosis crosstalk.J Ginseng Res. 2022 Jan;46(1):54-61. doi: 10.1016/j.jgr.2021.09.003. Epub 2021 Oct 5. J Ginseng Res. 2022. PMID: 35058727 Free PMC article. Review.
Cited by
-
Astragalus polysaccharides lowers plasma cholesterol through mechanisms distinct from statins.PLoS One. 2011;6(11):e27437. doi: 10.1371/journal.pone.0027437. Epub 2011 Nov 16. PLoS One. 2011. PMID: 22110652 Free PMC article.
-
Ginseng extract and ginsenoside Rb1 attenuate carbon tetrachloride-induced liver fibrosis in rats.BMC Complement Altern Med. 2014 Oct 25;14:415. doi: 10.1186/1472-6882-14-415. BMC Complement Altern Med. 2014. PMID: 25344394 Free PMC article.
-
Suppression of cholesterogenesis by plant constituents: review of Wisconsin contributions to NC-167.Lipids. 1985 Nov;20(11):817-24. doi: 10.1007/BF02534407. Lipids. 1985. PMID: 4068910
-
Regulation of appetite-related neuropeptides by Panax ginseng: A novel approach for obesity treatment.J Ginseng Res. 2022 Jul;46(4):609-619. doi: 10.1016/j.jgr.2022.03.007. Epub 2022 Apr 4. J Ginseng Res. 2022. PMID: 35818423 Free PMC article. Review.
-
Interaction of Veratrum nigrum with Panax ginseng against Obesity: A Sang-ban Relationship.Evid Based Complement Alternat Med. 2013;2013:732126. doi: 10.1155/2013/732126. Epub 2013 Sep 2. Evid Based Complement Alternat Med. 2013. PMID: 24073007 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous